The Bangladesh Export Processing Zones Authority (BEPZA) has secured a US $21.6 million investment from an Irish-Italian footwear company to build a manufacturing facility inside one of its export processing zones, Apparel Resources Bangladesh reports.

The commitment adds a European-backed player to Bangladesh's footwear manufacturing base, a tier of the supply chain that has grown steadily as brands diversify sourcing beyond China and Vietnam. Footwear remains the second-largest export earner after apparel in Bangladesh, and BEPZA zones have anchored much of that capacity.

The US $21.6 million figure covers the new facility, according to the report. The investor is identified as a firm with Irish and Italian ownership. Apparel Resources Bangladesh did not specify in the headline announcement which BEPZA zone will host the plant, the production timeline, or the projected headcount. Sourcing teams tracking Bangladeshi footwear capacity should treat those details as pending until BEPZA publishes its standard investment-approval disclosure.

For buyers, the significance is straightforward. European-owned footwear capacity in Bangladesh deepens the pool of suppliers able to serve EU accounts, where Bangladesh already enjoys duty-free access under the Everything But Arms scheme. A vertically foreign-owned plant with Irish-Italian backing also gives compliance teams a European parent entity to trace against supply-chain due-diligence obligations, including the EU Corporate Sustainability Due Diligence Directive as it phases in.

BEPZA has positioned itself as the gateway for such commitments, marketing plug-and-play infrastructure, bonded-warehouse benefits and repatriation guarantees to export manufacturers. Each new investment approval strengthens the authority's pitch that Bangladesh can absorb footwear orders seeking alternatives to saturated capacity in Vietnam and rising cost bases in southern China.

The decision this news forces on sourcing desks is an evaluation one: whether Bangladeshi EPZ-based footwear capacity — now with an additional European-owned option at the US $21.6 million scale — merits a place on vendor shortlists for 2025-26 programmes, and whether compliance files should open now while allocation in the new facility is still available.